The economic consequences of breast cancer adjuvant hormonal treatments.
about
Socioeconomic Disparities in Mortality Among Women With Incident Breast Cancer Before and After Implementation of Medicare Part DMedicare D Subsidies and Racial Disparities in Persistence and Adherence With Hormonal Therapy.Socioeconomic factors associated with adjuvant hormone therapy use in older breast cancer survivorsPatient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations.Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patientsAre survivors who report cancer-related financial problems more likely to forgo or delay medical care?Cost-related medication nonadherence and cost-saving strategies used by elderly Medicare cancer survivors.The perceived cancer-related financial hardship among patients and their families: a systematic review.Financial burden of colorectal cancer treatment among patients and their families in a middle-income country.Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors.Racial and ethnic disparities in cost-related medication non-adherence among cancer survivors.Gender differences in cost-related medication non-adherence among cancer survivors.Cost-effectiveness of full coverage of aromatase inhibitors for Medicare beneficiaries with early breast cancer.
P2860
Q33563718-0F5F8E2E-DD6E-4982-804B-E50E39506D44Q33756382-356CC40C-E844-4095-A3C7-709BE54B5299Q34442127-3D819946-BC96-4052-8D98-BAC191929635Q35060868-45097D75-4801-4852-B35F-A22190E37630Q35194455-7C6D0CE0-FA3D-4041-AD58-31A013790F73Q36003894-462990A4-4864-4D4B-B7C7-228ED5CEDE87Q37157162-EDF65A4A-9023-425E-9BAD-DF34053C8DE0Q38261967-495CBF8E-A0FB-4940-B48F-78D8D096656EQ39736103-F8615AA9-FC58-4FA6-8FEF-E5BA49A20E7FQ39908855-34C80682-3ED4-4AE4-9FFE-C748EFCFD813Q40259785-B96CBA32-7103-42BA-80AB-7C3D12D671DFQ40561326-24CFDAD7-0D8A-4EE6-A666-3F7A5F2359E1Q43935033-559D78C8-2484-4606-8DDD-DCEE7C8257F1
P2860
The economic consequences of breast cancer adjuvant hormonal treatments.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
The economic consequences of breast cancer adjuvant hormonal treatments.
@en
The economic consequences of breast cancer adjuvant hormonal treatments.
@nl
type
label
The economic consequences of breast cancer adjuvant hormonal treatments.
@en
The economic consequences of breast cancer adjuvant hormonal treatments.
@nl
prefLabel
The economic consequences of breast cancer adjuvant hormonal treatments.
@en
The economic consequences of breast cancer adjuvant hormonal treatments.
@nl
P2093
P2860
P1476
The economic consequences of breast cancer adjuvant hormonal treatments.
@en
P2093
Ann B Nattinger
Liliana E Pezzin
Mallory B O'Niel
P2860
P2888
P304
P356
10.1007/S11606-009-1079-5
P478
24 Suppl 2
P577
2009-11-01T00:00:00Z